Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Unihealth Hospitals Ltd (UNIHEALTH)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: UNIHEALTH Hospital & Healthcare Services | Small Cap | Unihealth Hospitals Share Price
BSE Share Price
Not Listed
Not Listed
Unihealth Hospitals Ltd (UNIHEALTH)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: UNIHEALTH Hospital & Healthcare Services | Small Cap | Unihealth Hospitals Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹1,101 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹15.1
TTM Sales
₹132 Cr.
Book Value per Share
₹80.2
P/E Ratio
42.62
Lower than its 5-year historical median
Industry PE
98.6
Price to Book (P/B)
8.00
Higher than its 5-year historical median
Price to Sales (P/S)
8.34
Lower than its 5-year historical median
EV/EBITDA
18.90
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
38.28%
Outperforms industry median
Return on Capital Employed (ROCE)
35.16%
Outperforms industry median
Return on Assets (ROA)
20.68%
Operating Profit Margin
40.8%
Net Profit Margin
34.43%
Gross Profit Margin
42.8%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
83.71%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
46.25%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
67.59%
Asset Quality
Promoter Holding
69.53%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹120 Cr.
Equity
₹17.2 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
Quality
Somewhat GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Weak
Is Unihealth Hospitals Ltd a good quality company?
Unihealth Hospitals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Unihealth Hospitals Ltd performance compare with that of its Peers?
Revenue growth of Unihealth Hospitals Ltd vs industry peers?
Unihealth Hospitals Ltd revenue CAGR is 38.17%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Unihealth Hospitals Ltd?
Promoters hold 69.53% of the Unihealth Hospitals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Unihealth Hospitals Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 70.25% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Unihealth Hospitals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -2.7% | 10.8% | 10.6% | 9% | 4.8% | 12% | - |
| Value Creation Index ⓘ | -1.2 | -0.2 | -0.2 | -0.4 | -0.7 | -0.1 | - |
Growth Parameters ⓘ |
|||||||
| Sales ⓘ | 0.6 | 1.6 | 1.9 | 4.2 | 3.6 | 6.5 | 7 |
| Sales YoY Gr. | - | 155.6% | 19.3% | 120.3% | -15.8% | 83.7% | - |
| Adj EPS ⓘ | -0.9 | 0.3 | 0.7 | 1.9 | 1.3 | 2.9 | 3.8 |
| YoY Gr. | - | NA | 140% | 168.1% | -31.6% | 118.2% | - |
| BVPS (₹) ⓘ | 5.6 | 6.1 | 11.4 | 41.9 | 43.3 | 49.6 | 46.2 |
| Adj Net Profit ⓘ | -1 | 0.3 | 0.8 | 3 | 2 | 4.5 | 6 |
| Cash Flow from Ops. ⓘ | -0.3 | 2.3 | 2 | -2.4 | -0.8 | 4 | - |
| Debt/CF from Ops. ⓘ | -21.7 | 5.2 | 6.1 | -1.4 | -3.2 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 59.7% | 50.5% | 83.7% | ||||
| Adj EPS ⓘ | NA | NA | 58.7% | 118.2% | ||||
| BVPSⓘ | NA | 54.6% | 63.2% | 14.4% | ||||
| Share Price | - | - | 71.1% | 291.9% | ||||
Key Financial Parameters ⓘ
| Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -16.8 | 5.2 | 8.4 | 7.7 | 3.1 | 6.2 | 7.9 |
| Op. Profit Mgn % ⓘ | -17.1 | 50.8 | 29.3 | 46.7 | 6.8 | 38 | NAN |
| Net Profit Mgn % ⓘ | -161.7 | 20.2 | 41.6 | 70.3 | 57.1 | 69.2 | 99.1 |
| Debt to Equity ⓘ | 1.2 | 1.8 | 1 | 0.1 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 2,207 | 2,660 | 1,626 | 2,713 | 2,173 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 363 | 236 | 132 | 271 | 184 | 0 |
Valuation of Unihealth Hospitals - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Sales | 22 | 26 | 37 | 44 | 49 | 99 | 132 |
| Operating Expenses ⓘ + | 20 | 20 | 25 | 30 | 31 | 62 | 78 |
| Operating Profit ⓘ | 2 | 7 | 12 | 14 | 18 | 37 | 54 |
| Operating Profit Margin (%) | 9.6% | 24.9% | 31.2% | 31.0% | 36.3% | 37.1% | 40.8% |
| Other Income ⓘ + | 1 | 2 | 1 | 2 | 2 | 3 | 5 |
| Interest ⓘ | 2 | 1 | 5 | 4 | 3 | 3 | 2 |
| Depreciation ⓘ | 2 | 2 | 2 | 3 | 2 | 6 | 10 |
| Profit Before Tax ⓘ | -1 | 5 | 5 | 9 | 14 | 30 | 46 |
| Tax ⓘ | 0 | 1 | 1 | 2 | 3 | 3 | 1 |
| Profit After Tax | -1 | 5 | 4 | 8 | 10 | 27 | 45 |
| PAT Margin (%) | -4.2% | 18.9% | 10.3% | 17.4% | 21.3% | 27.4% | 34.4% |
| Adjusted EPS (₹) | -0.8 | 4.7 | 3.6 | 6.9 | 6.7 | 9.2 | 16.5 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 6 | 11 | 15 | 28 | 85 | 101 | 136 | ||||
| Debt + | 40 | 38 | 38 | 39 | 12 | 10 | 20 | ||||
| Minority Interest | -0 | -0 | -0 | -0 | -0 | 40 | 60 | ||||
| Trade Payables | 6 | 2 | 2 | 3 | 2 | 6 | 9 | ||||
| Others Liabilities ⓘ | 7 | 8 | 11 | 9 | 11 | 27 | 29 | ||||
| Total Liabilities ⓘ | 58 | 58 | 65 | 78 | 110 | 185 | 254 | ||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 35 | 35 | 36 | 37 | 36 | 68 | 84 | ||||
| CWIP ⓘ | 2 | 0 | 0 | 0 | 0 | 5 | 10 | ||||
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Inventories | 1 | 1 | 2 | 2 | 2 | 4 | 7 | ||||
| Trade Receivables | 13 | 14 | 18 | 27 | 34 | 82 | 123 | ||||
| Cash Equivalents | 1 | 2 | 2 | 2 | 29 | 16 | 10 | ||||
| Others Assets ⓘ | 6 | 5 | 6 | 10 | 10 | 10 | 19 | ||||
| Total Assets ⓘ | 58 | 58 | 65 | 78 | 110 | 185 | 254 | ||||
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 1 | 4 | 9 | 1 | 5 | 3 | 6 |
| Cash Flow From Investing Activity ⓘ + | -2 | -0 | -2 | -5 | -2 | -5 | -24 |
| Cash Flow From Financing Activity ⓘ + | 1 | -3 | -5 | 3 | 21 | -3 | 16 |
| Net Cash Flow ⓘ | -0 | 0 | 2 | -0 | 24 | -5 | -2 |
| PARTICULARS | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | -16.31 | 60.42 | 29.75 | 36.19 | 18.39 | 29.04 | 38.28 | |||
| ROCE (%) | 1.8 | 14.12 | 20.33 | 22.11 | 20.33 | 30.73 | 35.16 | |||
| Asset Turnover Ratio | 0.38 | 0.45 | 0.6 | 0.61 | 0.52 | 0.67 | 0.6 | |||
| PAT to CFO Conversion(x) | N/A | 0.8 | 2.25 | 0.13 | 0.5 | 0.11 | 0.13 | |||
| Working Capital Days | ||||||||||
| Receivable Days | 206.10 | 186.20 | 160.40 | 189.40 | 228.20 | 213.20 | 284.20 | |||
| Inventory Days | 12.30 | 15.40 | 16.20 | 16.20 | 15.70 | 11.60 | 15.30 | |||
| Payable Days | 382.20 | 212.60 | 73.20 | 110.50 | 114.50 | 73.30 | 107.90 | |||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Unihealth Hospitals Ltd FAQs
The current trading price of Unihealth Hospitals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Unihealth Hospitals stood at ₹1,100.9 Cr
The latest P/E ratio of Unihealth Hospitals as of 31-Dec-1969 is 169.6.
The latest P/B ratio of Unihealth Hospitals as of 31-Dec-1969 is 13.89.
The 52-week high of Unihealth Hospitals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Unihealth Hospitals is ₹6.54 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Unihealth Hospitals Ltd is a average quality company.
The key valuation ratios of Unihealth Hospitals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Unihealth Hospitals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Unihealth Hospitals Ltd
Unihealth Hospitals (UniHealth) (Formerly known as Unihealth Consultancy) is a healthcare delivery company with a presence across India and Africa. Headquartered in Mumbai, the Company operates under the brand UMC Hospitals and provides tertiary and secondary care services through hospitals, medical centres, and specialized facilities. Its operations in Africa include multi-specialty hospitals and medical centres offering a broad range of services such as orthopedics, neurology, oncology, minimally invasive surgeries, nephrology, gynecology, pediatrics, dermatology, and cosmetology. The company complements these with dedicated facilities for diagnostics, dialysis, and consultations.
In India, UniHealth is steadily building its footprint in healthcare delivery, supported by its experience in operating diverse healthcare formats overseas. The company’s approach combines clinical expertise with modern infrastructure and a patient-first philosophy, enabling it to serve communities with accessible, affordable, and reliable care.
Business verticals:
Hospitals & Medical Centers: The Company runs hospitals under its flagship brand ‘UMC Hospitals’.
Healthcare Consultancy: UniHealth’s consultancy vertical provides end-to-end advisory solutions for healthcare projects across geographies.
Distribution & Trade: UniHealth is an authorized distributor of medical consumables and pharmaceutical products.
Medical Value Travel: UniHealth facilitates medical travel for international patients seeking advanced treatment in India through a seamless, end-to-end service model.
Business area of the company
UniHealth is predominantly engaged in business of Medical Tour Operator, Health Consultancy Service and Trading in Medical Equipments.
Awards & recognitions
- 2014: Awarded the ‘Best Medical Tourism Company of the Year 2014’ by Worldwide Achievers.
- 2015: Awarded ‘Emerging Healthcare Company of the Year’ at Business Leaders’ Summit & Awards 2015
- 2015: Awarded ‘Company of the Year for Valued Contribution in Indian Medical Tourism Industry’ at CIMS Healthcare Excellence Awards 2015.
- 2016: Awarded the ‘India 5000 Best MSME Award for Quality Excellence’ at India 5000 Best MSME Awards.
- 2018: Awarded the winner for ‘Company with Global Presence’ at the Small Enterprise Business Expo & Awards 2018.
- 2023: ‘UMC Hospitals UniHealth’ awarded the ‘Iconic Brand of the Year 2023’ by Blossom Media and BSE SME.
- 2023: ‘Company of the Year 2023 - Global’
Milestones
- 2010: UniHealth was incorporated with a focus on Medical Value Travel facilitation as its initial business vertical.
- 2011: The Company entered into an exclusive collaboration with Aditya Birla Memorial Hospital to provide medical value travel services.
- 2012: UniHealth successfully executed its first international healthcare consultancy project in Zimbabwe.
- 2014: The Company partnered with Ethiopian Airlines to launch the UniHealth–Ethiopian Air Medical Travel Program.
- 2015: UniHealth adopted the motto ‘Where Care Comes First’ and the vision ‘Healthcare for All’.
- 2016: The first UniHealth Medical Centre was commissioned in Mwanza, Tanzania, followed by another in Kampala, Uganda.
- 2017: UMC Victoria Hospital was commissioned in Kampala, Uganda, along with UMC Zhahir Hospital in Kano, Nigeria.
- 2018: The main wing of UMC Victoria Hospital was commissioned, further expanding its service capacity.
- 2019: UniHealth was appointed as Project Management Consultant for the 500-bed PHRC Health City in Pune, India.
- 2020: The Company set up the largest private COVID-19 treatment centre in Uganda and entered the distribution of medical consumables and pharmaceuticals in select African markets.
- 2022: UniHealth was converted into a Public Limited Company and renamed UniHealth Consultancy Limited.
- 2023: The Company was listed on NSE Emerge and signed an MoU with Maykhalar Group to develop a 300-bed Health City in Yangon, Myanmar.
- 2024: Statutory approval was received to change the name from Unihealth Consultancy Limited to Unihealth Hospitals Limited. The year also saw new collaborations in pharmaceuticals and medical travel.
- 2025: UniHealth is preparing to operationalize its first multispecialty hospital in Navi Mumbai, Maharashtra, under the UniHealth- UMC Hospitals Group.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
